Matrix metalloproteinase dysregulation in the stria vascularis of mice with Alport syndrome: Implications for capillary basement membrane pathology

American Journal of Pathology

Volumn 166, Issue 5, 2005, Pages 1465-1474

  Gratton, Michael Anne ^a   Rao, Velidi H ^b   Meehan, Daniel T ^b   Askew, Charles ^a   Cosgrove, Dominic ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN IV ALPHA3; COLLAGEN IV ALPHA4; COLLAGEN IV ALPHA5; COLLAGEN TYPE 4; GELATIN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ALPORT SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; COCHLEA; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENE MUTATION; GLOMERULOPATHY; KNOCKOUT MOUSE; MEMBRANE COMPONENT; METABOLISM; MICRODISSECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STRIA VASCULARIS; ZYMOGRAPHY;

EID: 17844408713     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62363-2     Document Type: Article

References (45)

1. Kashtan CE: Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine (Baltimore) 1999, 78:338-360
2. Sayers R, Kalluri R, Rodgers KD, Shield III CF, Meehan DT, Cosgrove DE: Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int 1999, 56:1662-1673
3. Cosgrove D, Rodgers KD, Meehan DT, Miller C, Bovard K, Gilroy A, Gardner HA, Kotelianski V, Gotwals P, Amatucci A, Kalluri R: Integrin α1β1 and transforming growth factor-β1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am J Pathol 2000, 157:1649-1659
4. Kashtan CE, Kim Y, Lees GE, Thorner PS, Virtanen I, Miner JH: Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. J Am Soc Nephrol 2001, 12:252-260
5. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WT, Samuelson GC: Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev 1996, 10:2981-2992
6. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen α3(IV): implications for Alport syndrome. J Cell Biol 1996, 135:1403-1413
7. Sayers R, Kalluri R, Rodgers KD, Shield CF, Meehan DT, Cosgrove D: Role for transforming growth factor-beta 1 in Alport renal disease progression. Kidney Int 1999, 56:1662-1673
8. Andrews KL, Mudd JL, Li C, Miner JH: Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome. Am J Pathol 2002, 160:721-730
9. Abrahamson DR, Prettyman AC, Robert B, St John PL: Laminin-1 reexpression in Alport mouse glomerular basement membranes. Kidney Int 2003, 63:826-834
10. Rodgers KD, Rao V, Meehan DT, Fager N, Gotwals P, Ryan ST, Koteliansky V, Nemori R, Cosgrove D: Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis. Kidney Int 2003, 63:1338-1355
11. Heidet L, Borza DB, Jouin M, Sich M, Mattel MG, Sado Y, Hudson BG, Hastie N, Antignac C, Gubler MC: A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal pheno-type in Col4a3-/- Alport mice. Kidney Int 2003, 64:1986-1996
12. Gross O, Beirowski B, Koepke ML, Kuck J, Reiner M, Addicks K, Smyth N, Schulze-Lohoff E, Weber M: Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int 2003, 63:438-446
13. Proesmans W, Van Dyck M: Enalapril in children with Alport syndrome, Pediatr Nephrol 2004, 19:271-275
14. Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, Siegel M: Ultrastructural, physiological and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear Res 1998, 121:84-98
15. Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT, Rodgers K, Berridge BR, Bhattacharya G, Cosgrove D: Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 2003, 63:1736-1748
16. Giannelli G, Antonaci S: Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol Histopathol 2002, 17:339-345
17. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, Xu L, Eng F, Afdhal N, Kalluri R: Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003, 124:147-159
18. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R: Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 2002, 160:2001-2008
19. Wilson CL, Matrisian LM: Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Biol 1996, 28:123-136
20. Bhattacharya G, Miller C, Kimberling WJ, Jablonski MM, Cosgrove D: Localization and expression of usherin: a novel basement membrane protein defective in people with Usher syndrome type IIa. Hear Res 2002, 163:1-11
21. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkens NA, Copeland NG, Sanes JR: The laminin alpha chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol 1997, 137:685-701
22. Rodgers KD, Barritt LC, Miner JH, Cosgrove D: The laminins in the murine inner ear: developmental transitions and expression in cochlear basement membranes. Hear Res 2001, 158:39-50
23. Gronski Jr TJ, Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD: Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem 1997, 272:12189-12194
24. MacPherson LJ, Bayburt EK, Capparelli MP: Discovery of CGS27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem 1997, 40:2525-2532
25. Lehti K, Valtenen H, Keski-Oja J: Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 1998, 334:345-353
26. Rezzani R, Angoscini P, Rodella L, Bianchi R: Alterations induced by cyclosporine A in myocardial fibers and extracellular matrix in rat. Histol Histopathol 2002, 17:761-766
27. Jeng AY, Chou M, Sawyer WK, Caplan SL, Von Linden-Reed J, Jeune M, Prescott MF: Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis. Ann NY Acad Sci 1999, 878:555-558
28. Lelongt B, Legallicier B, Piedagnel R, Ronco PM: Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypertens 2001, 10:7-12
29. Noirey N, Staquet MJ, Gariazzo MJ, Serres M, Andre C, Schmitt D, Vincent C: Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. Eur J Cell Biol 2002, 81:383-389
30. McKaig KC, McWilliams D, Watson SA, Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 2003, 162:1355-1360
31. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003, 9:964-968
32. Wang S, Hirschberg R; BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol 2003, 284:F1006-F1013
33. Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, Noonan DM, Nalali PG, Albini A: The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000, 87:336-342
34. Esparza J, Vilardell C, Calvo J, Juan M, Vives J, Urbano-Marquez A, Yague J, Cid MC: Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through TAS/MAP kinase signaling pathways. Blood 1999, 94:2754-2766
35. Langholz O, Rockel D, Mauch C, Kozlowska E, Bank I, Krieg T, Eckes B: Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995, 131:1903-1915
36. Huhtala P, Humphries MH, McCarthy JB, Trernble PM, Werb Z, Damsky CH: Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995, 129:867-879
37. Gratton MA, Meehan DT, Smyth BJ, Cosgrove D: Striai marginal cells play a role in basement membrane homeostasis: in vitro and in vivo evidence. Hear Res 2002, 163:27-36
38. Weidauer H, Arnold W: Strukturelle veranderungen am hororgan beim Alport syndrome. Z Laryngol Rhinol Otol 1976, 55:6-16
39. Merchant SN, Burgess BJ, Adams JC, Kashtan CE, Gregory MC, Santi PA, Colvin R, Colfins B, Nadol JB: Temporal bone histopathology in Alport syndrome. Laryngoscope 2004, 114:1609-1618
40. Thomopoulos GN, Spicer SS, Gratton MA, Schulte BA: Age-related thickening of basement membrane in stria vascularis capillaries. Hear Res 1997, 111:31-41
41. Gratton MA, Schulte BA: Alterations in microvasculature are associated with atrophy of the stria vascularis in quiet-aged gerbils. Hear Res 1995, 82:44-52
42. Smith TL, Raynor E, Prazma J, Buenting JE, Pillsbury HC: Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 1995, 105:236-240
43. McMenomey SO, Russell NJ, Morton JI, Trune DR: Stria vascularis ultrastructural pathology in the C3H/Ipr autoimmune strain mouse: a potential mechanism for immune-related hearing loss. Otolaryngol Head Neck Surg 1992, 106:288-295
44. Sone M, Naruichi H, Saito K, Yanagita N: A substrain of the NZB mouse as an animal model of autoimmune inner ear disease. Hear Res 1995, 83:26-36
45. Lamm K, Zajic G, Schacht J: Living isolated cells from inner ear vessels: a new approach for studying the regulation of cochlear microcirculation and vascular permeability. Hear Res 1994, 81:83-90